We’re one step closer to hypoallergenic cats—researchers just used CRISPR to delete the stuff that makes people sneeze.
March 20, 2026
Original Paper
Structure-guided deimmunisation of Fel d 1 suppresses allergic effector functions ex vivo
bioRxiv · 10.64898/2026.03.18.712552
The Takeaway
By targeting the specific protein (Fel d 1) that causes most cat allergies in humans, scientists created a blueprint for genetically engineering hypoallergenic cats. The study confirms that this genetic edit doesn't harm the cat's health, providing a foundation for future allergy-free pets.
From the abstract
Allergic responses to the major cat allergen Fel d 1 are primarily driven by immunoglobulin E (IgE) cross-linking on effector cells. While conventional allergen-specific immunotherapies often rely on whole-allergen extracts with inherent risks of systemic reactions, rationally engineered variants offer a safer path to desensitisation. We present a structure-guided strategy to deimmunise Fel d 1 by selectively disrupting crucial IgE-binding interfaces. Using a computational pipeline integrating s